Shares of Shire PLC (LON:SHP) have received a consensus recommendation of “Buy” from the nineteen ratings firms that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is GBX 5,845.60 ($77.54).
SHP has been the subject of several recent research reports. Deutsche Bank AG reissued a “buy” rating and issued a GBX 6,000 ($79.59) price target on shares of Shire PLC in a research report on Tuesday, June 27th. Citigroup Inc. reissued a “buy” rating and issued a GBX 6,500 ($86.22) price target on shares of Shire PLC in a research report on Thursday, June 22nd. Shore Capital reissued a “buy” rating on shares of Shire PLC in a research report on Wednesday, June 21st. Societe Generale reissued a “buy” rating and issued a GBX 7,500 ($99.48) price target on shares of Shire PLC in a research report on Wednesday, July 12th. Finally, Jefferies Group LLC decreased their price target on shares of Shire PLC from GBX 5,600 ($74.28) to GBX 5,250 ($69.64) and set a “buy” rating for the company in a research report on Monday, August 7th.
In other Shire PLC news, insider Flemming Ornskov acquired 8,400 shares of the company’s stock in a transaction on Tuesday, August 22nd. The shares were bought at an average cost of GBX 3,665 ($48.61) per share, for a total transaction of £307,860 ($408,356.55). Also, insider Anne Minto acquired 190 shares of the company’s stock in a transaction on Friday, September 29th. The stock was acquired at an average price of GBX 3,785 ($50.21) per share, for a total transaction of £7,191.50 ($9,539.06).
TRADEMARK VIOLATION WARNING: This piece was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://transcriptdaily.com/2017/10/08/shire-plc-shp-receives-average-rating-of-buy-from-analysts.html.
Shares of Shire PLC (LON:SHP) traded down 0.86% during trading on Friday, reaching GBX 3862.00. 1,331,925 shares of the company were exchanged. The firm has a 50-day moving average price of GBX 3,850.16 and a 200-day moving average price of GBX 4,287.07. Shire PLC has a 1-year low of GBX 3,603.50 and a 1-year high of GBX 5,331.00. The stock’s market capitalization is GBX 35.01 billion.
The business also recently declared a dividend, which will be paid on Friday, October 20th. Investors of record on Thursday, September 7th will be paid a dividend of GBX 3.85 ($0.05) per share. The ex-dividend date is Thursday, September 7th. This represents a yield of 0.1%.
Shire PLC Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.